Dave brings 20 years of experience working with Fortune 500 and biotech executive teams on R&D portfolio management / strategy, product commercialization, and business development. While the span of his work includes all major therapeutic areas, particular areas of focus have included oncology, hematology, immunology, and pulmonology including orphan disease sub-segments.
Prior to joining Clearview, Dave led business development & strategy for Surface Oncology, a publicly traded immuno-oncology biotech. Before Surface, he had responsibility for worldwide commercial strategy for Bristol-Myers Squibb’s immuno-oncology portfolio which saw over 200 approvals across 50+ countries in ~3 years. Dave also brings extensive management consulting experience having served on the leadership team of The Frankel Group, now part of Huron Consulting, and in the life sciences practice of Deloitte Consulting.
Dave holds a B.S. in Computer Science and Business from Muhlenberg College and an MBA in Finance and Healthcare from the Wharton School of Business.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian
Vini De Nadai